STATE STREET CORP - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 127 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.6%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2023$2,198,795
-10.2%
42,366
+3.7%
0.00%
Q2 2023$2,449,606
+26.5%
40,854
+4.3%
0.00%
Q1 2023$1,936,367
-53.2%
39,166
-45.9%
0.00%
Q4 2022$4,135,292
+884.6%
72,460
+709.5%
0.00%
Q3 2022$420,000
-5.0%
8,951
-24.4%
0.00%
Q2 2022$442,000
+104.6%
11,834
+87.4%
0.00%
Q4 2021$216,000
-6.1%
6,316
+1.9%
0.00%
Q3 2021$230,0006,2000.00%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$29,942,30435.70%
RTW INVESTMENTS, LP 6,096,387$316,402,4856.68%
Paradigm Biocapital Advisors LP 1,384,686$71,865,2034.88%
Rock Springs Capital Management LP 2,943,710$152,778,5494.09%
Logos Global Management LP 450,000$23,355,0003.12%
TANG CAPITAL MANAGEMENT LLC 405,600$21,050,6402.97%
GREAT POINT PARTNERS LLC 290,917$15,098,5922.75%
Nicholas Investment Partners, LP 512,855$26,617,1751.99%
Eschler Asset Management LLP 30,000$1,557,0001.82%
COWEN AND COMPANY, LLC 460,036$23,875,8681.67%
View complete list of IMMUNOCORE HLDGS PLC shareholders